U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07761728) titled 'The FLARE (Flurpiridaz vs. Rubidium Evaluation) Trial' on July 26.
Brief Summary: This study seeks to evaluate if the diagnostic performance of 18F-flurpiridaz positron emission tomography (PET) myocardial perfusion imaging (MPI), given the radiotracer's properties, is non-inferior to the currently most widely utilized PET MPI radiopharmaceutical, 82Rb-chloride.
Study Start Date: Aug. 13, 2025
Study Type: OBSERVATIONAL
Condition:
Coronary Artery Disease
Coronary Microvascular Disease
Recruitment Status: RECRUITING
Sponsor: University of California, Los Angeles
Information provided by (Responsible Party): Rene R. Sevag Packard...